Literature DB >> 2580304

Influenza viral (A/WSN/33) hemagglutinin is expressed and glycosylated in the yeast Saccharomyces cerevisiae.

M A Jabbar, N Sivasubramanian, D P Nayak.   

Abstract

Recombinant plasmids were constructed in which genes coding for either the entire or the signal-minus (amino acid residues 2-17 deleted) hemagglutinin (HA) of WSN influenza virus were placed under the control of the alcohol dehydrogenase I gene promoter of Saccharomyces cerevisiae. Both recombinant plasmids were shown to direct the synthesis of HA-specific polypeptides that were detected by immunoprecipitation with antiviral antibodies. The complete HA produced in yeast had an approximate Mr of 70,000 and was glycosylated, as determined by the endoglycosidase H sensitivity, and was bound to membrane. Therefore, the complete HA polypeptide possessing the signal sequence probably traversed the yeast secretory pathways. Signal-minus HA, on the other hand, had a lower molecular weight and was nonglycosylated. The specific binding of yeast HA with antiviral antibodies could be competitively inhibited by influenza viral HA, demonstrating that the HA produced in yeast contained antigenic determinants of the native viral HA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580304      PMCID: PMC397479          DOI: 10.1073/pnas.82.7.2019

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Isolation and chemical characterization of plasma membranes from the yeast and mycelial forms of Candida albicans.

Authors:  M S Marriott
Journal:  J Gen Microbiol       Date:  1975-01

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Expression of antigenic determinants of the hemagglutinin gene of a human influenza virus in Escherichia coli.

Authors:  A R Davis; D P Nayak; M Ueda; A L Hiti; D Dowbenko; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

Review 4.  Synthesis and processing of asparagine-linked oligosaccharides.

Authors:  S C Hubbard; R J Ivatt
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

5.  Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus.

Authors:  D P Nayak; K Tobita; J M Janda; A R Davis; B K De
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

6.  The release of intact oligosaccharides from specific glycoproteins by endo-beta-N-acetylglucosaminidase H.

Authors:  A L Tarentino; T H Plummer; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

7.  Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related.

Authors:  A L Hiti; A R Davis; D P Nayak
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

8.  Construction and characterization of a bacterial clone containing the hemagglutinin gene of the WSN strain (HON1) of influenza virus.

Authors:  A R Davis; A L Hiti; D P Nayak
Journal:  Gene       Date:  1980-08       Impact factor: 3.688

9.  Expression of a human gene for interferon in yeast.

Authors:  R A Hitzeman; F E Hagie; H L Levine; D V Goeddel; G Ammerer; B D Hall
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

10.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies.

Authors:  W Gerhard; J Yewdell; M E Frankel; R Webster
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

View more
  11 in total

1.  Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells.

Authors:  Y Kawaoka; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.

Authors:  Felix W Santiago; Kris Lambert Emo; Theresa Fitzgerald; John J Treanor; David J Topham
Journal:  Vaccine       Date:  2012-05-15       Impact factor: 3.641

3.  Signal processing, glycosylation, and secretion of mutant hemagglutinins of a human influenza virus by Saccharomyces cerevisiae.

Authors:  M Abdul Jabbar; D P Nayak
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

4.  Expression of the RNA genome of an animal virus in Saccharomyces cerevisiae.

Authors:  M Makarow; L T Nevalainen; L Kääriäinen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Regulated expression of Sindbis and vesicular stomatitis virus glycoproteins in Saccharomyces cerevisiae.

Authors:  D Z Wen; M J Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Molecular evolution of hemagglutinin genes of H1N1 swine and human influenza A viruses.

Authors:  S Sugita; Y Yoshioka; S Itamura; Y Kanegae; K Oguchi; T Gojobori; K Nerome; A Oya
Journal:  J Mol Evol       Date:  1991-01       Impact factor: 2.395

7.  Characterization of rabies glycoprotein expressed in yeast.

Authors:  S R Klepfer; C Debouck; J Uffelman; P Jacobs; A Bollen; E V Jones
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Abnormal growth induced by expression of HBsAg in the secretion pathway of S. cerevisiae pep4 mutants.

Authors:  D C Chen; L T Chuang; W P Chen; T T Kuo
Journal:  Curr Genet       Date:  1995-02       Impact factor: 3.886

9.  Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.

Authors:  Swati Verma; Milena Dimitrova; Ashok Munjal; Juan Fontana; Corey J Crevar; Donald M Carter; Ted M Ross; Surender Khurana; Hana Golding
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

10.  Yeast Surface-Displayed H5N1 Avian Influenza Vaccines.

Authors:  Han Lei; Sha Jin; Erik Karlsson; Stacey Schultz-Cherry; Kaiming Ye
Journal:  J Immunol Res       Date:  2016-12-19       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.